89bio, Inc.
ETNB
$9.04
$0.273.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -450.21M | -386.67M | -367.08M | -288.96M | -174.61M |
| Total Depreciation and Amortization | 35.00K | 39.00K | 38.00K | 45.00K | 47.00K |
| Total Amortization of Deferred Charges | 1.27M | 1.12M | 831.00K | 684.00K | 748.00K |
| Total Other Non-Cash Items | 17.80M | 15.82M | 12.92M | 11.90M | 9.86M |
| Change in Net Operating Assets | -8.00M | -30.15M | -14.53M | -4.20M | -1.58M |
| Cash from Operations | -439.10M | -399.84M | -367.82M | -280.54M | -165.54M |
| Capital Expenditure | -87.00K | -87.00K | -15.00K | -4.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -103.18M | 31.29M | -40.85M | -124.33M | -77.36M |
| Cash from Investing | -103.27M | 31.20M | -40.86M | -124.33M | -77.37M |
| Total Debt Issued | 9.35M | 9.35M | 9.35M | 9.35M | 0.00 |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 452.54M | 459.10M | 212.14M | 237.75M | 213.12M |
| Repurchase of Common Stock | -2.52M | -1.99M | -2.65M | -2.63M | -3.32M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -137.00K | 0.00 | -253.00K | -116.00K | -116.00K |
| Cash from Financing | 459.23M | 466.46M | 218.59M | 244.35M | 209.68M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -83.14M | 97.82M | -190.10M | -160.52M | -33.22M |